751611118	751611118	CD	B-NP	O
|	|	NNP	I-NP	O
WH	WH	NNP	I-NP	O
|	|	VBD	B-VP	O
51425337	51425337	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
640656	640656	CD	B-NP	O
|	|	CC	I-NP	O
4/20/1998	4/20/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
UNSTABLE	UNSTABLE	NNP	I-NP	I-protein
ANGINA	ANGINA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/20/1998	4/20/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/19/1999	7/19/1999	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
VASOSPASM	VASOSPASM	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HYPERTRIGLYCERIDEMIA	HYPERTRIGLYCERIDEMIA	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PROTEINURIA	PROTEINURIA	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GASTROESOPHAGEAL	GASTROESOPHAGEAL	NN	B-NP	O
REFLUX	REFLUX	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GOUT	GOUT	NN	B-NP	O
.	.	.	O	O

OPERATIONS/PROCEDURES	OPERATIONS/PROCEDURES	NNP	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
4/25/98	4/25/98	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Cliff	Cliff	NNP	I-NP	O
Lucas	Lucas	NNP	I-NP	O
Man	Man	NNP	I-NP	O
Mcnease	Mcnease	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
52	52	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
Asian	Asian	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
In	In	IN	B-PP	O
1988	1988	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CABG	CABG	NN	I-NP	O
x2	x2	NN	I-NP	O
vessels	vessel	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
and	and	CC	I-NP	O
RIMA	RIMA	NN	I-NP	B-protein
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
PTCA	PTCA	NN	I-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
PTCA	PTCA	NN	I-NP	O
of	of	IN	B-PP	O
LAD	LAD	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
proximal	proximal	JJ	B-ADJP	O
to	to	TO	B-PP	O
LIMA	LIMA	NN	B-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
circumflex	circumflex	NN	B-NP	B-protein
-RRB-	-RRB-	HYPH	B-ADJP	I-protein
including	include	VBG	B-PP	O
stent	stent	NN	B-NP	O
in	in	IN	B-PP	O
10/6	10/6	CD	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
discharged	discharge	VBD	B-VP	O
himself	himself	PRP	B-NP	O
AMA	AMA	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
10/17/98	10/17/98	CD	B-NP	O
for	for	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
markedly	markedly	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
leads	lead	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
long	long	JJ	I-NP	O
instant	instant	JJ	I-NP	O
restenosis	restenosis	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
area	area	NN	I-NP	O
was	be	VBD	B-VP	O
rotablated	rotablate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
angioplastied	angioplastie	VBN	B-VP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
asystole	asystole	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
V-pacer	V-pacer	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
pacer	pacer	NN	I-NP	O
was	be	VBD	B-VP	O
D/C	D/C	NN	B-NP	O
'd	'd	MD	O	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
11/17/98	11/17/98	CD	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
pain	pain	RB	B-ADJP	O
free	free	JJ	I-ADJP	O
,	,	,	O	O
except	except	IN	B-PP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
exercises	exercise	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
treadmill	treadmill	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
takes	take	VBZ	B-VP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
before	before	IN	B-PP	O
and	and	CC	O	O
one	one	CD	B-NP	O
after	after	IN	B-SBAR	O
the	the	DT	B-NP	O
treadmill	treadmill	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
now	now	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
developed	develop	VBN	I-VP	O
rest	rest	NN	B-NP	O
angina	angina	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
q.	q.	VBN	I-VP	O
day	day	NN	B-NP	O
rest	rest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1-3	1-3	CD	I-NP	O
episodes	episode	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
relieved	relieve	VBN	B-VP	O
by	by	IN	B-PP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
and	and	CC	O	O
lasting	last	VBG	B-VP	O
for	for	IN	B-PP	O
minutes	minute	NNS	B-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
at	at	IN	B-PP	O
HEH	HEH	NN	B-NP	B-protein
for	for	IN	B-PP	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
started	start	VBD	B-VP	O
approximately	approximately	RB	B-ADVP	O
on	on	IN	B-PP	O
7/15/98	7/15/98	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
felt	feel	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
again	again	RB	B-ADVP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
stairs	stair	NNS	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reported	report	VBD	B-VP	O
this	this	DT	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
Cater	Cater	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
arm	arm	NN	B-NP	O
tingling	tingling	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
occasional	occasional	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
intermittent	intermittent	JJ	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

no	no	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
sleeps	sleep	VBZ	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
pillow	pillow	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
other	other	JJ	I-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
yellow	yellow	JJ	B-NP	O
phlegm	phlegm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
heparinized	heparinize	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Coronary	Coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	VBP	B-VP	O
a	a	DT	B-NP	O
CABG	CABG	NN	I-NP	B-protein
in	in	IN	B-PP	O
1988	1988	CD	B-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
PTCA	PTCA	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Status	Status	NNP	I-NP	O
post	post	NN	I-NP	O
rotablation	rotablation	NN	I-NP	O
in	in	IN	B-PP	O
11/25	11/25	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hyperlipidemia	Hyperlipidemia	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Focal/segmental	Focal/segmental	JJ	I-NP	O
glomerulosclerosis	glomerulosclerosis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
3.4	3.4	CD	B-NP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
last	last	JJ	I-NP	O
dye	dye	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Chronic	Chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gout	Gout	NNP	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Status	Status	NNP	I-NP	O
post	post	NN	I-NP	O
lap	lap	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
9	9	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Ecotrin	Ecotrin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
SL	SL	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
;	;	:	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Vitamin	Vitamin	NN	B-NP	O
E	E	NN	I-NP	O
400	400	CD	I-NP	O
U	U	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
allopurinol	allopurinol	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NNPS	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
Naprosyn	Naprosyn	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
renal	renal	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
quit	quit	VB	B-VP	O
years	year	NNS	B-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
sister	sister	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NNS	I-NP	O
:	:	:	O	O
Temp	Temp	NN	B-NP	B-protein
97.8	97.8	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
67	67	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
146/98	146/98	CD	I-NP	I-DNA
,	,	,	O	O
satting	satte	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
Asian	Asian	JJ	I-NP	O
male	male	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
eyes	eye	NNS	I-NP	O
were	be	VBD	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
showed	show	VBD	B-VP	O
moist	moist	NN	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
approximately	approximately	RB	B-NP	O
10-11	10-11	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
II/VI	II/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
upper	upper	JJ	B-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
positive	positive	JJ	B-NP	B-protein
S4	S4	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
.	.	.	O	O

LUNGS	LUNGS	NNS	B-NP	O
:	:	:	O	O
Rales	Rale	NNS	B-NP	B-protein
1/2	1/2	CD	B-NP	I-protein
to	to	TO	B-PP	O
3/4	3/4	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Obese	Obese	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
2	2	CD	B-NP	I-protein
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
film	film	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
AP	AP	NN	I-NP	O
done	do	VBN	B-VP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
infiltrates	infiltrate	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
brady	brady	NN	I-NP	O
-	-	HYPH	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
first	first	JJ	B-NP	O
degree	degree	NN	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Laboratories	Laboratory	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
9	9	CD	B-NP	O
and	and	CC	I-NP	O
1.4	1.4	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
6.37	6.37	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
43	43	CD	I-NP	O
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
146	146	CD	I-NP	I-protein
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
90	90	CD	I-NP	I-protein
,	,	,	O	O
troponin-I	troponin-I	NN	B-NP	O
0.06	0.06	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
12.3	12.3	CD	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
32.7	32.7	CD	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Sunier	Sunier	NNP	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
R/O	R/O	NN	B-NP	B-protein
MI	MI	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
did	do	VBD	I-VP	O
R/O	R/O	NN	B-NP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
and	and	CC	I-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
heparinized	heparinize	VBN	I-VP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
on	on	IN	B-PRT	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
nitropaste	nitropaste	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
him	him	PRP	B-NP	O
pain	pain	VB	B-VP	O
free	free	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
nitropaste	nitropaste	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
,	,	,	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
headache	headache	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
cross-cover	cross-cover	JJ	I-NP	O
intern	intern	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
4	4	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
10	10	CD	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
deep	deep	JJ	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
stated	state	VBN	B-VP	O
felt	feel	VBD	B-VP	O
like	like	IN	B-PP	O
his	his	PRP$	B-NP	O
typical	typical	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
nitropaste	nitropaste	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
within	within	IN	B-PP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
borderline	borderline	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ETT	ETT	NN	I-NP	B-DNA
MIBI	MIBI	NN	I-NP	I-DNA
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
9/17/98	9/17/98	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
exercise	exercise	VBP	B-VP	O
approximately	approximately	RB	B-NP	O
9	9	CD	I-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
45	45	CD	B-NP	O
seconds	second	NNS	I-NP	O
and	and	CC	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
89	89	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
BP	BP	NN	B-NP	B-protein
170/98	170/98	CD	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
horizontal	horizontal	JJ	B-NP	O
downsloping	downsloping	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
,	,	,	O	O
ST	ST	JJ	B-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
leads	lead	NNS	I-NP	O
and	and	CC	I-NP	O
V5-V6	V5-V6	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
persistent	persistent	JJ	B-ADJP	O
in	in	IN	B-PP	O
recovery	recovery	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
got	get	VBD	B-VP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
given	give	VBN	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
images	image	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
showed	show	VBD	B-VP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Moderate	Moderate	NNP	I-NP	O
to	to	TO	B-VP	O
severe	severe	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
septum	septum	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
RCA	RCA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
7	7	CD	I-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
20	20	CD	I-NP	B-DNA
segments	segment	NNS	I-NP	I-DNA
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Mild	Mild	NNP	I-NP	O
ischemia	ischemia	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
and	and	CC	I-NP	O
septum	septum	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LAD	LAD	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4	4	CD	I-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
20	20	CD	I-NP	B-DNA
segments	segment	NNS	I-NP	I-DNA
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
An	An	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
59	59	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
nitropaste	nitropaste	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
A	A	NN	I-NP	O
left	left	JJ	I-NP	O
main	main	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
okay	okay	NN	B-NP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Totally	Totally	NNP	I-NP	O
occluded	occlude	VBD	B-VP	O
RCA	RCA	NN	B-NP	B-protein
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Totally	Totally	RB	B-ADVP	O
occluded	occlude	VBD	B-VP	O
LAD	LAD	NN	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
D1	D1	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
His	His	PRP$	B-NP	B-protein
left	left	JJ	I-NP	O
circ	circ	NN	I-NP	O
was	be	VBD	B-VP	O
30-40	30-40	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mid	mid	JJ	I-NP	O
instant	instant	JJ	I-NP	O
occlusion	occlusion	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
was	be	VBD	B-VP	O
patent	patent	NN	B-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
A	A	NN	I-NP	O
treated	treat	VBN	B-VP	O
LIMA	LIMA	NNP	B-NP	O
,	,	,	O	O
gaze	gaze	VB	B-VP	O
TNG	TNG	NN	B-NP	O
arrow	arrow	NN	I-NP	O
patent	patent	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	VBD	B-VP	O
RIMA	RIMA	NNP	B-NP	O
PTCA/stenting	PTCA/stenting	NNP	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
spasm	spasm	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
RIMA	RIMA	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
PTCA	PTCA	NN	B-NP	B-protein
stenting	stente	VBG	B-VP	O
performed	perform	VBN	B-ADJP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
some	some	DT	B-NP	O
vasospasm	vasospasm	NN	I-NP	O
on	on	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Isordil	Isordil	NN	B-NP	O
and	and	CC	I-NP	O
nifedipine	nifedipine	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
spasm	spasm	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
develop	develop	VB	I-VP	O
any	any	DT	B-NP	O
complications	complication	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
a	a	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
or	or	CC	O	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
9/19/99	9/19/99	CD	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Allopurinol	Allopurinol	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
ECASA	ECASA	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
lisinopril	lisinopril	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lopressor	Lopressor	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
nifedipine	nifedipine	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
tab	tab	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
;	;	:	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Vitamin	Vitamin	NN	B-NP	O
E	E	NN	I-NP	O
400	400	CD	I-NP	O
U	U	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
;	;	:	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
x30	x30	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Croom	Croom	NNP	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
MICKEY	MICKEY	NNP	B-NP	O
MENDEL	MENDEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
UJ21	UJ21	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DARRYL	DARRYL	NNP	B-NP	O
B.	B.	NNP	I-NP	O
TOEPEL	TOEPEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QG8	QG8	NNP	I-NP	O
CL522/5469	CL522/5469	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
65590	65590	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

HJFHTP26R	HJFHTP26R	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/22/99	1/22/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/17/99	1/17/99	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

WILLY	WILLY	NNP	B-NP	O
H.	H.	NNP	I-NP	O
BINK	BINK	NNP	I-NP	O
,	,	,	O	O
M.D	M.D	NNP	B-NP	O
.	.	.	O	O

